GO:0090222 centrosome-templated microtubule nucleation: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0090222 describes the de novo formation of a microtubule from the centrosome, where tubulin heterodimers form metastable oligomeric aggregates.
• The centrosome acts as the primary microtubule-organizing center (MTOC) in animal cells, and its nucleation capacity is essential for spindle assembly, cell polarity, and intracellular transport.
• Gamma-tubulin ring complex (gamma-TuRC) is the core nucleator, but efficient centrosome-templated nucleation requires additional factors such as ch-TOG and CAMSAPs.
• Nucleation is not a simple template reaction; it involves conformational changes in gamma-TuRC and regulated release of newly formed microtubules.
• Dysregulation of centrosome-templated microtubule nucleation is linked to cancer, neurodevelopmental disorders, and neurodegeneration.
• Researchers study this process using live-cell imaging, in vitro reconstitution, and CRISPR-based knockout or knock-in models targeting nucleation factors.
Description
Centrosome-templated microtubule nucleation (GO:0090222) is the process by which new microtubules are formed de novo from the centrosome, a major microtubule-organizing center in animal cells. This biological process is fundamental for building the microtubule cytoskeleton, which controls cell shape, polarity, division, and intracellular transport. The centrosome provides a template for the assembly of tubulin heterodimers into metastable oligomeric aggregates, initiating microtubule polymerization. Understanding this process is critical because it determines how cells organize their microtubule arrays in space and time, impacting development and disease. At the molecular level, centrosome-templated nucleation depends on the gamma-tubulin ring complex (gamma-TuRC), a large multiprotein complex that serves as a structural template for microtubule assembly. However, recent work has shown that nucleation is not a passive process; it requires nucleation-promoting factors such as ch-TOG and involves conformational changes in gamma-TuRC that regulate the release of newly formed microtubules. These findings have reshaped our understanding of how microtubules are born at the centrosome. For researchers, GO:0090222 represents a convergence point for cell biology, structural biology, and disease modeling. Defects in centrosome-templated nucleation are associated with cancer, neurodevelopmental disorders, and neurodegeneration, making it a target for mechanistic studies and therapeutic development. This article provides a comprehensive overview of the definition, mechanism, key genes, research methods, and CRISPR models relevant to this process.
centrosome-templated microtubule nucleation At A Glance
| GO ID | GO:0090222 |
|---|---|
| GO term | centrosome-templated microtubule nucleation |
| Ontology | biological_process |
| Synonym | None |
| Major function | De novo formation of microtubules from the centrosome |
| Cellular location | Centrosome |
| Key molecular players | Gamma-tubulin ring complex (gamma-TuRC), ch-TOG, CAMSAPs |
| Associated processes | Spindle assembly, cell polarity, intracellular transport |
| Disease relevance | Cancer, neurodevelopmental disorders, neurodegeneration |
What Is GO:0090222?
GO:0090222, centrosome-templated microtubule nucleation, is defined as the de novo formation of a microtubule in which tubulin heterodimers form metastable oligomeric aggregates from the centrosome. In simpler terms, it is the birth of a new microtubule at the centrosome, the cell's primary microtubule-organizing center. This process is distinct from other modes of microtubule nucleation because it specifically uses the centrosome as a template and initiation site.
Why Is centrosome-templated microtubule nucleation Important in Cell Biology?
Centrosome-templated microtubule nucleation is essential for fundamental cellular processes such as mitosis, cell migration, and organelle positioning. It determines the spatial organization of the microtubule cytoskeleton, which in turn regulates cell shape and polarity. Defects in this process can lead to chromosomal instability, developmental abnormalities, and neurodegenerative diseases. Therefore, understanding its mechanism is crucial for both basic cell biology and translational research.
• Controls spindle assembly and chromosome segregation during mitosis.
• Regulates cell polarity and migration in development and tissue homeostasis.
• Essential for neuronal differentiation and axon guidance.
• Dysregulation leads to centrosome amplification and cancer.
• Implicated in neurodevelopmental disorders such as microcephaly.
• Contributes to neurodegeneration through defective microtubule dynamics.
• Target for anti-cancer drugs that inhibit microtubule nucleation.
• Key area for understanding cytoskeleton organization in health and disease.
What Happens During centrosome-templated microtubule nucleation?
Initiation at the centrosome
In simple terms: The centrosome starts the process by providing a platform for new microtubules to form.
The centrosome, composed of two centrioles surrounded by pericentriolar material (PCM), recruits gamma-tubulin ring complex (gamma-TuRC) to initiate microtubule nucleation. Gamma-TuRC serves as a template that mimics the plus-end of a microtubule, allowing tubulin heterodimers to assemble into a nascent microtubule. This step is tightly regulated and requires the localization of gamma-TuRC to the centrosome, which depends on factors such as ch-TOG.
Tubulin oligomerization and metastable aggregates
In simple terms: Tubulin proteins come together to form small, unstable clusters that can grow into a microtubule.
Tubulin heterodimers (alpha/beta-tubulin) associate with gamma-TuRC to form metastable oligomeric aggregates. These aggregates are intermediates that can either disassemble or proceed to form a stable microtubule. The process is energetically unfavorable and requires the template provided by gamma-TuRC. Recent structural studies have revealed that gamma-TuRC undergoes a conformational change from an open to a closed state during nucleation, which stabilizes the growing microtubule.
Microtubule elongation and release
In simple terms: The new microtubule grows longer and then detaches from the centrosome to function elsewhere.
Once nucleation is initiated, the microtubule elongates by addition of tubulin dimers at its plus end. The newly formed microtubule can then be released from the centrosome, a process regulated by CAMSAPs and other nucleation-promoting factors. This release is crucial for generating free microtubules that can be transported to other cellular locations. The balance between nucleation and release determines the density and organization of the microtubule network.
Regulation by nucleation-promoting factors
In simple terms: Helper proteins control when and where microtubules are made.
Nucleation-promoting factors such as ch-TOG and CAMSAPs modulate the activity of gamma-TuRC and the stability of nascent microtubules. ch-TOG is required for gamma-TuRC centrosome localization in interphase cells, and its depletion reduces nucleation. CAMSAPs control the release of microtubules from gamma-TuRC, ensuring proper cytoskeletal dynamics. These factors integrate cellular signals to fine-tune microtubule nucleation in response to developmental and environmental cues.
Key Genes Involved in GO:0090222 centrosome-templated microtubule nucleation
The following genes and proteins are key players in centrosome-templated microtubule nucleation, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TUBG1 | Gamma-tubulin, core component of gamma-TuRC | Essential for nucleation; mutations linked to neurodevelopmental disorders |
| TUBG2 | Gamma-tubulin isoform | Potential redundancy with TUBG1 in some tissues |
| TUBGCP2 | Gamma-TuRC subunit | Required for complex assembly and centrosome localization |
| TUBGCP3 | Gamma-TuRC subunit | Mutations associated with microcephaly |
| TUBGCP4 | Gamma-TuRC subunit | Structural role in gamma-TuRC |
| TUBGCP5 | Gamma-TuRC subunit | Implicated in neurodevelopmental disorders |
| TUBGCP6 | Gamma-TuRC subunit | Mutations cause microcephaly and retinal abnormalities |
| NEDD1 | Gamma-TuRC targeting to centrosome | Regulates nucleation during mitosis |
| CDK5RAP2 | Centrosomal protein, gamma-TuRC recruitment | Mutations linked to microcephaly |
| AKAP9 | Centrosomal scaffold protein | Regulates gamma-TuRC anchoring |
| ch-TOG (CKAP5) | Nucleation-promoting factor | Required for gamma-TuRC centrosome localization and nucleation |
| CAMSAP1 | Microtubule minus-end regulator | Controls microtubule release from gamma-TuRC |
| CAMSAP2 | Microtubule minus-end regulator | Controls microtubule release from gamma-TuRC |
| CAMSAP3 | Microtubule minus-end regulator | Controls microtubule release from gamma-TuRC |
| PCNT | Pericentriolar material component | Scaffolds gamma-TuRC at centrosome |
| CEP192 | Centrosomal protein | Essential for centrosome maturation and nucleation |
| PLK1 | Mitotic kinase | Regulates centrosome maturation and nucleation |
| AURKA | Mitotic kinase | Regulates centrosome maturation and nucleation |
How Is centrosome-templated microtubule nucleation Regulated?
Centrosome-templated microtubule nucleation is regulated by cell cycle-dependent phosphorylation and the activity of mitotic kinases such as PLK1 and AURKA, which control centrosome maturation and gamma-TuRC recruitment. Additionally, nucleation-promoting factors like ch-TOG and CAMSAPs modulate the efficiency of nucleation and microtubule release. The process is also influenced by the availability of tubulin dimers and the structural conformation of gamma-TuRC.
centrosome-templated microtubule nucleation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TUBGCP2 | Microcephaly | Knockout in neural stem cells |
| TUBGCP6 | Microcephaly with retinal abnormalities | Knock-in of patient mutations in iPSCs |
| CDK5RAP2 | Microcephaly | Knockout in mouse models |
| CKAP5 (ch-TOG) | Cancer | Overexpression in cancer cell lines |
| CAMSAP2 | Neurodevelopmental disorders | Knockout in neurons |
Cancer
Centrosome amplification and aberrant microtubule nucleation are hallmarks of many cancers, leading to multipolar spindles and chromosomal instability. Overexpression of nucleation factors such as ch-TOG has been observed in various tumors and correlates with poor prognosis. Targeting centrosome-templated nucleation is a potential therapeutic strategy.
Neurodevelopmental disorders
Mutations in genes encoding gamma-TuRC components (e.g., TUBGCP2, TUBGCP4, TUBGCP6) and centrosomal proteins (e.g., CDK5RAP2) cause microcephaly and other neurodevelopmental disorders. Defective nucleation impairs neuronal progenitor proliferation and differentiation.
Neurodegeneration
Disrupted microtubule nucleation contributes to neurodegeneration by impairing axonal transport and neuronal polarity. In neurons, centrosome-templated nucleation is essential for axon outgrowth and regeneration.
From centrosome-templated microtubule nucleation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the effect of complete loss of gamma-TuRC component? | Knockout cell lines (e.g., TUBGCP2 KO) |
| How do patient mutations affect nucleation? | Point mutation knock-in (e.g., TUBGCP6 missense) |
| Where and when is gamma-TuRC localized? | Tagged knock-in (e.g., GFP-TUBG1) |
| What happens when nucleation is overactivated? | Overexpression of ch-TOG or CAMSAPs |
| Which genes are essential for nucleation? | CRISPR library screening |
| How does nucleation change in cancer? | Patient-derived organoids with knockout of candidate genes |
How to Study the centrosome-templated microtubule nucleation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Live-cell imaging | Nucleation events, microtubule dynamics | Visualizing nucleation in real time |
| In vitro reconstitution | Minimal components for nucleation | Mechanistic studies of gamma-TuRC |
| Proteomics | Protein interactions | Identifying novel nucleation factors |
| CRISPR knockout screens | Gene essentiality for nucleation | Discovering new regulators |
| Electron microscopy | Structural changes in gamma-TuRC | Understanding conformational transitions |
| Microtubule regrowth assay | Nucleation capacity after depolymerization | Quantifying nucleation efficiency |
| FRAP | Turnover of nucleation factors | Measuring dynamics at centrosome |
Live-cell imaging
Live-cell imaging of fluorescently labeled tubulin or gamma-TuRC allows real-time visualization of microtubule nucleation at the centrosome. This method measures nucleation events, microtubule growth rates, and release dynamics.
In vitro reconstitution
Purified gamma-TuRC and tubulin can be used to reconstitute nucleation in vitro, providing mechanistic insights into the minimal components required. This approach is powerful for studying the effect of mutations and regulatory factors.
Proteomics and interactomics
Affinity purification coupled with mass spectrometry can identify novel interactors of gamma-TuRC and nucleation-promoting factors. This helps map the protein network controlling nucleation.
CRISPR-based genetic screens
Genome-wide CRISPR knockout screens can identify genes required for centrosome-templated nucleation, using readouts such as microtubule regrowth after cold treatment. This unbiased approach reveals new regulators.
How CRISPR Can Be Used to Study GO:0090222 centrosome-templated microtubule nucleation
Knockout
CRISPR knockout of genes such as TUBGCP2 or CKAP5 (ch-TOG) can abolish centrosome-templated nucleation, leading to mitotic defects and cell death. These models are used to study the essentiality of nucleation factors and their role in development.
Point Mutation
Introducing patient-derived point mutations (e.g., in TUBGCP6) via CRISPR knock-in allows researchers to study how specific amino acid changes affect gamma-TuRC assembly and nucleation. This is crucial for understanding disease mechanisms.
Knock-in
Tagged knock-in of endogenous genes (e.g., GFP-TUBG1) enables live-cell imaging of gamma-TuRC dynamics at the centrosome. This approach preserves endogenous regulation and provides physiological relevance.
Overexpression
CRISPR activation or cDNA overexpression of nucleation-promoting factors like ch-TOG can increase nucleation efficiency, modeling cancer-associated overexpression. This helps identify downstream effects on spindle assembly and chromosome segregation.
How EDITGENE Supports centrosome-templated microtubule nucleation Research
Researchers studying centrosome-templated microtubule nucleation-related genes often need to determine whether a candidate gene is causally involved in the process, and how mutations affect function. EDITGENE provides a comprehensive suite of CRISPR services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for centrosome-templated microtubule nucleation research.
Frequently Asked Questions About centrosome-templated microtubule nucleation
What is centrosome-templated microtubule nucleation?
It is the de novo formation of a microtubule from the centrosome, where tubulin heterodimers form metastable oligomeric aggregates, as defined by GO:0090222.
What genes are involved in centrosome-templated microtubule nucleation?
Key genes include TUBG1, TUBGCP2-6, NEDD1, CDK5RAP2, AKAP9, CKAP5 (ch-TOG), and CAMSAP1-3.
What is the role of gamma-TuRC in microtubule nucleation?
Gamma-TuRC acts as a structural template that mimics the plus-end of a microtubule, allowing tubulin dimers to assemble into a new microtubule.
How is centrosome-templated microtubule nucleation regulated?
It is regulated by cell cycle kinases (PLK1, AURKA), nucleation-promoting factors (ch-TOG, CAMSAPs), and conformational changes in gamma-TuRC.
What diseases are associated with defects in centrosome-templated microtubule nucleation?
Defects are linked to cancer, microcephaly, neurodevelopmental disorders, and neurodegeneration.
How can I study centrosome-templated microtubule nucleation in the lab?
Common methods include live-cell imaging, in vitro reconstitution, proteomics, and CRISPR screens.
What is the difference between centrosome-templated and other microtubule nucleation?
Centrosome-templated nucleation specifically uses the centrosome as the initiation site, whereas other modes (e.g., chromatin-mediated) occur elsewhere.
Can CRISPR be used to model mutations in nucleation genes?
Yes, CRISPR knockout, point mutation knock-in, and tagged knock-in are powerful approaches to study gene function in nucleation.
What is ch-TOG and why is it important for nucleation?
ch-TOG (CKAP5) is a nucleation-promoting factor required for gamma-TuRC centrosome localization and efficient microtubule nucleation.
What are CAMSAPs and how do they relate to nucleation?
CAMSAPs are microtubule minus-end regulators that control the release of newly nucleated microtubules from gamma-TuRC.
Conclusion
Centrosome-templated microtubule nucleation (GO:0090222) is a fundamental biological process that governs microtubule organization and cellular architecture. Its mechanism involves the coordinated action of gamma-TuRC, nucleation-promoting factors, and regulatory kinases. Dysregulation of this process contributes to cancer, neurodevelopmental disorders, and neurodegeneration, making it a critical area of research. Advances in CRISPR-based models and imaging technologies continue to unravel the complexities of nucleation, offering new opportunities for therapeutic intervention.
References
- 1. Pereira G et al.. 1997. Centrosome-microtubule nucleation.. J Cell Sci 110 ( Pt 3):295-300 PMID: 9057082
- 2. Ezquerra A et al.. 2020. Assaying Microtubule Nucleation.. Methods Mol Biol 2101:163-178 PMID: 31879904
- 3. Ali A et al.. 2023. Microtubule nucleation and γTuRC centrosome localization in interphase cells require ch-TOG.. Nat Commun 14(1):289 PMID: 36702836
- 4. Job D et al.. 2003. Microtubule nucleation.. Curr Opin Cell Biol 15(1):111-7 PMID: 12517712
- 5. Rai D et al.. 2024. CAMSAPs and nucleation-promoting factors control microtubule release from γ-TuRC.. Nat Cell Biol 26(3):404-420 PMID: 38424271
- 6. Roostalu J et al.. 2017. Microtubule nucleation: beyond the template.. Nat Rev Mol Cell Biol 18(11):702-710 PMID: 28831203
- 7. Brito C et al.. 2024. Transition of human γ-tubulin ring complex into a closed conformation during microtubule nucleation.. Science 383(6685):870-876 PMID: 38305685
- 8. Yu W et al.. 1993. Microtubule nucleation and release from the neuronal centrosome.. J Cell Biol 122(2):349-59 PMID: 8320258
